Market Cap

Creo Medical Limited Market Capitalization:

£41.9 Million

GBP as of Jan. 1, 2026

US$56.3 Million

business Creo Medical Limited Company Profile

Creo Medical Limited Main Stock Listing

LSE: CREO

Market Capitalization History of Creo Medical Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $216.15 B
Boston Scientific Corporation $140.40 B
Stryker $133.15 B
Medtronic $123.20 B
Edwards Lifesciences Corporation $50.10 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Creo Medical Limited market cap

Date Market Cap YoY Change
Jan. 1, 2026 £41.9 M -46.38%
Jan. 1, 2025 £78.1 M -53.01%
Jan. 1, 2024 £166.2 M 322.08%
Jan. 1, 2023 £39.4 M -83.13%
Jan. 1, 2022 £233.3 M -40.97%
Jan. 1, 2021 £395.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Creo Medical Limited Categories

United Kingdom languages Healthcare languages Medical Devices
United Kingdom Healthcare United Kingdom Medical Devices

Stocks & Indices

Creo Medical Limited has the following listings and related stock indices.


Stock: LSE: CREO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.